FI118204B - Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet - Google Patents
Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet Download PDFInfo
- Publication number
- FI118204B FI118204B FI964285A FI964285A FI118204B FI 118204 B FI118204 B FI 118204B FI 964285 A FI964285 A FI 964285A FI 964285 A FI964285 A FI 964285A FI 118204 B FI118204 B FI 118204B
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical preparation
- radical
- preparation according
- phospholipids
- docetaxel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9404951 | 1994-04-25 | ||
FR9404951A FR2718963B1 (fr) | 1994-04-25 | 1994-04-25 | Nouvelle composition pharmaceutique à base de taxoïdes. |
FR9500532 | 1995-04-24 | ||
PCT/FR1995/000532 WO1995028923A1 (fr) | 1994-04-25 | 1995-04-24 | Compositions pharmaceutiques a base de derives de la classe des taxanes |
Publications (3)
Publication Number | Publication Date |
---|---|
FI964285A FI964285A (fi) | 1996-10-24 |
FI964285A0 FI964285A0 (fi) | 1996-10-24 |
FI118204B true FI118204B (fi) | 2007-08-31 |
Family
ID=9462475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI964285A FI118204B (fi) | 1994-04-25 | 1996-10-24 | Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet |
Country Status (26)
Country | Link |
---|---|
US (1) | US5670536A (xx) |
EP (1) | EP0758231B1 (xx) |
JP (1) | JP3950993B2 (xx) |
KR (1) | KR100401119B1 (xx) |
CN (1) | CN1283243C (xx) |
AT (1) | ATE202931T1 (xx) |
AU (1) | AU691283B2 (xx) |
BR (1) | BR9507846A (xx) |
CZ (1) | CZ285720B6 (xx) |
DE (1) | DE69521693T2 (xx) |
DK (1) | DK0758231T3 (xx) |
ES (1) | ES2160163T3 (xx) |
FI (1) | FI118204B (xx) |
FR (1) | FR2718963B1 (xx) |
GE (1) | GEP20002069B (xx) |
GR (1) | GR3036211T3 (xx) |
HU (1) | HU225971B1 (xx) |
NO (1) | NO314745B1 (xx) |
NZ (1) | NZ285122A (xx) |
PL (1) | PL179623B1 (xx) |
PT (1) | PT758231E (xx) |
RU (1) | RU2157200C2 (xx) |
SK (1) | SK283255B6 (xx) |
TW (1) | TW416849B (xx) |
WO (1) | WO1995028923A1 (xx) |
ZA (1) | ZA953358B (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2698871B1 (fr) | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
US6395770B1 (en) | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
CN100462066C (zh) * | 1997-06-27 | 2009-02-18 | 美国生物科学有限公司 | 药剂的新制剂及其制备和应用方法 |
US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
NZ506389A (en) * | 1998-02-05 | 2003-07-25 | Novartis Ag | Pharmaceutical compositions containing epothilone which can be optionally lyophilised |
US6071952A (en) * | 1998-12-02 | 2000-06-06 | Mylan Pharmaceuticals, Inc. | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
GB9920548D0 (en) * | 1999-08-31 | 1999-11-03 | Rhone Poulenc Rorer Sa | Treatment of hepatocellular carcinoma |
DE10255285A1 (de) * | 2002-11-26 | 2004-06-03 | Mcs Micro Carrier Systems Gmbh | Selbst formende Phospholipid-Gele |
US20050152979A1 (en) * | 2003-09-05 | 2005-07-14 | Cell Therapeutics, Inc. | Hydrophobic drug compositions containing reconstitution enhancer |
US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
US7446126B2 (en) * | 2004-10-08 | 2008-11-04 | Indena S.P.A. | Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
EP2146695A4 (en) * | 2007-04-23 | 2010-05-19 | Sun Pharmaceuticals Ind Ltd | PHARMACEUTICAL COMPOSITIONS |
EP1987813A1 (en) * | 2007-05-04 | 2008-11-05 | Pharmatex Italia Srl | Injectable pharmaceutical formulation of taxoids in stable liposomes |
WO2009047794A2 (en) * | 2007-10-01 | 2009-04-16 | Intas Pharmaceuticals Limited | Taxane derivative composition |
US7895009B2 (en) * | 2007-11-07 | 2011-02-22 | Amfit, Inc. | Impression foam digital scanner |
ES2344674B1 (es) * | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
US8541360B2 (en) * | 2008-11-19 | 2013-09-24 | Ben Venue Laboratories, Inc. | Parenteral formulations comprising sugar-based esters and ethers |
WO2012156999A1 (en) * | 2011-05-19 | 2012-11-22 | Manu Chaudhary | Ready to use docetaxel formulation |
JP5847942B2 (ja) | 2012-07-19 | 2016-01-27 | 富士フイルム株式会社 | タキサン系活性成分含有液体組成物、その製造方法及び液体製剤 |
EA022182B1 (ru) * | 2012-12-24 | 2015-11-30 | Общество С Ограниченной Ответственностью "Технология Лекарств" | Способ получения липосомальной формы доцетаксела |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4534899A (en) * | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
US4507217A (en) * | 1983-03-07 | 1985-03-26 | Lipid Specialties, Inc. | Magnetic compositions and magnetic memory devices prepared therefrom |
US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
ATE194767T1 (de) * | 1992-03-23 | 2000-08-15 | Univ Georgetown | In liposomen verkapseltes taxol und verwendungsverfahren |
AU6833994A (en) * | 1993-05-17 | 1994-12-12 | Liposome Company, Inc., The | Incorporation of taxol into liposomes and gels |
WO1994026253A1 (en) * | 1993-05-19 | 1994-11-24 | The Liposome Company, Inc. | Liposome having a multicomponent bilayer which contains a bioactive agent as an integral component of the bilayer |
US5415869A (en) * | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
-
1994
- 1994-04-25 FR FR9404951A patent/FR2718963B1/fr not_active Expired - Lifetime
-
1995
- 1995-04-24 KR KR1019960705981A patent/KR100401119B1/ko not_active IP Right Cessation
- 1995-04-24 CZ CZ963093A patent/CZ285720B6/cs not_active IP Right Cessation
- 1995-04-24 AT AT95918046T patent/ATE202931T1/de active
- 1995-04-24 NZ NZ285122A patent/NZ285122A/en not_active IP Right Cessation
- 1995-04-24 RU RU96122523/14A patent/RU2157200C2/ru not_active IP Right Cessation
- 1995-04-24 HU HU9602942A patent/HU225971B1/hu not_active IP Right Cessation
- 1995-04-24 CN CNB951927280A patent/CN1283243C/zh not_active Expired - Fee Related
- 1995-04-24 SK SK1356-96A patent/SK283255B6/sk not_active IP Right Cessation
- 1995-04-24 PL PL95316942A patent/PL179623B1/pl not_active IP Right Cessation
- 1995-04-24 JP JP52740795A patent/JP3950993B2/ja not_active Expired - Fee Related
- 1995-04-24 DE DE69521693T patent/DE69521693T2/de not_active Expired - Lifetime
- 1995-04-24 PT PT95918046T patent/PT758231E/pt unknown
- 1995-04-24 DK DK95918046T patent/DK0758231T3/da active
- 1995-04-24 AU AU24126/95A patent/AU691283B2/en not_active Ceased
- 1995-04-24 EP EP95918046A patent/EP0758231B1/fr not_active Expired - Lifetime
- 1995-04-24 BR BR9507846A patent/BR9507846A/pt not_active IP Right Cessation
- 1995-04-24 WO PCT/FR1995/000532 patent/WO1995028923A1/fr active IP Right Grant
- 1995-04-24 ES ES95918046T patent/ES2160163T3/es not_active Expired - Lifetime
- 1995-04-24 TW TW084104022A patent/TW416849B/zh not_active IP Right Cessation
- 1995-04-24 GE GEAP19953465A patent/GEP20002069B/en unknown
- 1995-04-25 ZA ZA953358A patent/ZA953358B/xx unknown
- 1995-04-25 US US08/428,261 patent/US5670536A/en not_active Expired - Lifetime
-
1996
- 1996-10-18 NO NO19964433A patent/NO314745B1/no not_active IP Right Cessation
- 1996-10-24 FI FI964285A patent/FI118204B/fi not_active IP Right Cessation
-
2001
- 2001-07-12 GR GR20010400339T patent/GR3036211T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI118204B (fi) | Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet | |
KR0136722B1 (ko) | 택산류 유도체를 기재로한 신규한 조성물 | |
EP2054036B1 (en) | Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening | |
TW200522978A (en) | Tocopherol-modified therapeutic drug compounds | |
WO2001025223A1 (en) | Stabilization of taxane-containing dispersed systems | |
EP1694660B1 (en) | Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions | |
HUE034684T2 (en) | Drug dispensing system for the administration of poorly soluble pharmaceutical agents in water | |
TW422706B (en) | An oil-in-water emulsion type of paclitaxel | |
CA2701789A1 (fr) | Nouvelles compositions a base de taxoides | |
JP2019500406A (ja) | 抗癌薬の新規ナノ製剤及びその製造方法 | |
CN105380906A (zh) | 一种卡巴他赛肿瘤靶向脂质体注射剂及其制备方法 | |
FR2715846A1 (fr) | Nouvelle composition pharmceutique à base de taxoïdes. | |
US20070032438A1 (en) | Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions | |
CA2188599C (fr) | Compositions pharmaceutiques a base de derives de la classe des taxanes | |
CN101081219B (zh) | 一种含紫杉烷类化合物的组合物、其制备方法和用途 | |
SK287850B6 (sk) | Stable pharmaceutical form of the anti-cancer drug | |
WO2013026989A2 (fr) | Liposome comprenant au moins un derive de cholesterol | |
US20050129719A1 (en) | Concentrated emulsion formulation for silatecan | |
MXPA00004456A (en) | Pharmaceutical compositions containing cyclodextrins and taxoids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 118204 Country of ref document: FI |
|
MM | Patent lapsed |